Wednesday, February 04, 2026#HK #SDY #LiveDraw
Home / Detail

Biogen CEO Chris Viehbacher On 2026 Drug Pipeline Outlook, Rare Disease Strategy

By Team February 04, 2026

Coverage of Biogen CEO Chris Viehbacher On 2026 Drug Pipeline Outlook, Rare Disease Strategy.

You Might Also Like

CEO Chris Viehbacher Explains Biogen's Rare Disease Breakthrough Strategy

10 days ago

Biogen CEO Chris Viehbacher Praises PM Modi's Tech Vision After Roundtable Meeting in New York

1 year ago

PM Modi has a vision that 21st Century is driven by Technology: Chris Viehbacher, Biogen CEO

1 year ago

Biogen CEO Christopher Viehbacher breaks down his outlook for '23

3 years ago